13G Filing: Matrix Capital Management and Trillium Therapeutics Inc (TRIL)

Page 7 of 8 – SEC Filing

SIGNATURES

After reasonable
inquiry and to the best of his or its knowledge and belief, each of the undersigned certify that the information set forth in this
statement is true, complete and correct.

DATED: December 8, 2017

MATRIX CAPITAL MANAGEMENT COMPANY LP
By: /s/ David E. Goel
Name: David E. Goel
Title: Managing General Partner
/s/ David E. Goel
DAVID E. GOEL

Follow Trillium Therapeutics Inc. (NASDAQ:TRIL)